Skip to main content

Table 1 Clinical characteristics of patients diagnosed with stage III, grade III, serous ovarian epithelial cancer at Princess Margaret by length of survival

From: Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors

Covariate

Full Sample (n = 41)

LT (n = 20)

ST (n = 21)

p value

Number of patients

41

20

21

 

Stage III, HGSOC

41 (100)

20 (49)

21 (51)

 

Overall Survival

< 0.001

 < 6 months

0 (0)

0 (0)

0 (0)

 

 6–12 months

2 (5)

0 (0)

4 (19)

 

 12–24 months

19 (46)

0 (0)

17 (81)

 

 > 24 months

20 (49)

20 (100)

0 (0)

 

Age at diagnosis

0.024

 Mean (sd)

59 (9.3)

56.1 (9.4)

61.7 (8.7)

0.024

 Median (min,max)

57 (40,84)

55.5 (40,84)

59 (47,76)

 

Residual disease

0.012

 No

18 (44)

13 (65)

5 (24)

 

 Yes

23 (56)

7 (35)

16 (76)

 

Disease recurrence

< 0.001

 No

17 (41)

17 (85)

0 (0)

 

 Yes

24 (59)

3 (15)

21 (100)

 

Number of disease recurrence

< 0.001

 0

17 (41)

17 (85)

0 (0)

 

 1

15 (37)

1 (5)

14 (67)

 

 2

7 (17)

1 (5)

6 (29)

 

 > 2

2 (5)

1 (5)

1 (5)

 

CA125 at diagnosis

0.39

 Mean (sd)

1207 (1781.6)

870.4 (863.1)

1491 (2277.9)

 

 Median (min,max)

475 (67,9162)

585 (67,2700)

399 (184,9162)

 

 Missing

6

4

2

 

CA125 at diagnosis rate

0.41

 Unknown

6 (15)

4 (20)

2 (10)

 

 0–35 U/mL

0 (0)

0 (0)

0 (0)

 

 > 35 U/mL

35 (85)

16 (80)

19 (90)

 

CA125 post-surgery

< 0.001

 Mean (sd)

421 (932.4)

63.9 (74.8)

799.1 (1243.4)

 

 Median (min,max)

121 (7,4712)

33 (7299)

296 (53,4712)

 

 Missing

6

2

4

 

CA125 post-surgery rate

< 0.001

 Unknown

6 (15)

2 (10)

4 (19)

 

 0–35 U/mL

9 (22)

9 (45)

0 (0)

 

 > 35 U/mL

26 (63)

9 (45)

17 (81)

 

CA125 post chemotherapy

< 0.001

 Mean (sd)

656.4 (3772.9)

4.6 (2.1)

1308 (5325.7)

 

 Median (min,max)

6.5 (2,23,290)

4 (2,10)

18 (4, 23,287)

 

 Missing

3

1

2

 

CA125 post chemotherapy rate

0.0063

 Unknown

3 (7)

1 (5)

2 (10)

 

 0–35 U/mL

31 (76)

19 (95)

12 (57)

 

 > 35 U/mL

7 (17)

0 (0)

7 (33)

Â